Edition:
India

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,897.50GBp
16 Aug 2019
Change (% chg)

17.50 (+0.93%)
Prev Close
1,880.00
Open
1,880.00
Day's High
1,900.00
Day's Low
1,880.00
Volume
1,481,604
Avg. Vol
1,990,630
52-wk High
1,940.00
52-wk Low
1,242.50

Select another date:

Fri, May 17 2019

BRIEF-Dantax Receives Tender Offer For Its Shares In Opus Acoustics And Ansuz-Acoustics

* SAID ON THURSDAY RECEIVED TENDER OFFER FOR ALL ITS SHARES IN ASSOCIATED COMPANIES, OPUS ACOUSTICS AND ANSUZ-ACOUSTICS

Nivea-maker Beiersdorf buys Coppertone for $550 million

BERLIN Beiersdorf, the maker of Nivea and other skin care brands, is buying U.S. sun care brand Coppertone from Bayer for $550 million to strengthen its position in North America, the German consumer goods firm said on Monday.

Smith & Nephew boosts full-year outlook after Q1 growth

May 2 Medical products maker Smith & Nephew on Thursday forecast annual revenue growth at the top half of its previously estimated range after reporting a 4.4 percent rise in quarterly revenue on an underlying basis.

Nivea-maker Beiersdorf reports strong first quarter

BERLIN, April 30 German consumer goods firm Beiersdorf reported a strong start to the year on Tuesday on healthy sales of its Nivea skin cream after its new chief executive launched a new strategy to help the firm compete with niche brands.

Deals of the day-Mergers and acquisitions

March 12 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

Britain's Smith & Nephew to buy Osiris in regenerative products push

Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as the British medical products maker looks to bulk up in an area that is quickly growing.

UPDATE 1-Britain's Smith & Nephew to buy Osiris in regenerative products push

March 12 Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as the British medical products maker looks to bulk up in an area that is quickly growing.

Smith & Nephew to buy Osiris Therapeutics for $660 mln

March 12 British medical products maker Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as it looks to boost profit margins and find new sources of growth.

Select another date: